Role of signal transducer and activator of transcription 3 in regulation of hypothalamic Proopiomelanocortin gene expression by leptin

Endocrinology

Volumn 144, Issue 5, 2003, Pages 2121-2131

  Münzberg, Heike ^a   Huo, Lihong ^a   Nillni, Eduardo A ^b   Hollenberg, Anthony N ^a   Bjørbæk, Christian ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b RHODE ISLAND HOSPITAL   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEPTIN; PROOPIOMELANOCORTIN; STAT3 PROTEIN; TRANSCRIPTION FACTOR; CELL SURFACE RECEPTOR; DNA BINDING PROTEIN; LEPTIN RECEPTOR; PEPTIDE FRAGMENT; RECOMBINANT PROTEIN; STAT3 PROTEIN, HUMAN; STAT3 PROTEIN, MOUSE; STAT3 PROTEIN, RAT; TRANSACTIVATOR PROTEIN;

ANIMAL TISSUE; ARTICLE; ENERGY BALANCE; GENE EXPRESSION REGULATION; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; HUMAN TISSUE; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; MEDIATOR RELEASE; MEMBRANE POTENTIAL; NEUROSECRETORY CELL; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; TARGET CELL; ANIMAL; BINDING SITE; BRAIN; CYTOLOGY; DRUG EFFECT; GENETIC TRANSCRIPTION; GENETICS; MALE; METABOLISM; MOUSE; NERVE CELL; PHOSPHORYLATION; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; BINDING SITES; BRAIN; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HUMANS; HYPOTHALAMUS; HYPOTHALAMUS, MIDDLE; LEPTIN; MALE; MICE; NEURONS; PEPTIDE FRAGMENTS; PHOSPHORYLATION; PRO-OPIOMELANOCORTIN; PROMOTER REGIONS (GENETICS); RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CELL SURFACE; RECOMBINANT PROTEINS; STAT3 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC;

EID: 0038747134     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2002-221037     Document Type: Article

References (73)

1. Cone RD, Cowley MA, Butler AA, Fan W, Marks DL, Low MJ 2001 The arcuate nucleus as a conduit for diverse signals relevant to energy homeostasis. Int J Obes Relat Metab Disord 25(Suppl 5):S63-S67
2. Schwartz MW, Woods SC, Porte Jr D, Seeley RJ, Baskin DG 2000 Central nervous system control of food intake. Nature 404:661-671
3. Elias CF, Aschkenasi C, Lee C, Kelly J, Ahima RS, Bjorbaek C, Flier JS, Saper CB, Elmquist JK 1999 Leptin differentially regulates NPY and POMC neurons projecting to the lateral hypothalamic area. Neuron 23:775-786
4. Korner J, Savontaus E, Chua Jr SC, Leibel RL, Wardlaw SL 2001 Leptin regulation of Agrp and Npy mRNA in the rat hypothalamus. J Neuroendocrinol 13:959-966
5. Pritchard LE, Turnbull AV, White A 2002 Pro-opiomelanocortin processing in the hypothalamus: impact on melanocortin signalling and obesity. J Endocrinol 172:411-421
6. Baskin DG, Breininger JF, Schwartz MW 1999 Leptin receptor mRNA identifies a subpopulation of neuropeptide Y neurons activated by fasting in rat hypothalamus. Diabetes 48:828-833
7. Chen P, Li C, Haskell-Luevano C, Cone RD, Smith MS 1999 Altered expression of agouti-related protein and its colocalization with neuropeptide Y in the arcuate nucleus of the hypothalamus during lactation. Endocrinology 140:2645-2650
8. Mercer JG, Hoggard N, Williams LM, Lawrence CB, Hannah LT, Trayhurn P 1996 Localization of leptin receptor mRNA and the long form splice variant (Ob-Rb) in mouse hypothalamus and adjacent brain regions by in situ hybridization. FEBS Lett 387:113-116
9. Mercer JG, Hoggard N, Williams LM, Lawrence CB, Hannah LT, Morgan PJ, Trayhurn P 1996 Coexpression of leptin receptor and preproneuropeptide Y mRNA in arcuate nucleus of mouse hypothalamus. J Neuroendocrinol 8:733-735
10. Hahn TM, Breininger JF, Baskin DG, Schwartz MW 1998 Coexpression of Agrp and NPY in fasting-activated hypothalamic neurons. Nat Neurosci 1:271-272
11. Baskin DG, Schwartz MW, Seeley RJ, Woods SC, Porte Jr D, Breininger JF, Jonak Z, Schaefer J, Krouse M, Burghardt C, Campfield LA, Burn P, Kochan JP 1999 Leptin receptor long-form splice-variant protein expression in neuron cell bodies of the brain and colocalization with neuropeptide Y mRNA in the arcuate nucleus. J Histochem Cytochem 47:353-362
12. Elmquist JK, Bjorbaek C, Ahima RS, Flier JS, Saper CB 1998 Distributions of leptin receptor mRNA isoforms in the rat brain. J Comp Neurol 395:535-547
13. Cowley MA, Smart JL, Rubinstein M, Cerdan MG, Diano S, Horvath TL, Cone RD, Low MJ 2001 Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 411:480-484
14. Brown KS, Gentry RM, Rowland NE 1998 Central injection in rats of α-melanocyte-stimulating hormone analog: effects on food intake and brain Fos. Regul Pept 78:89-94
15. Murphy B, Nunes CN, Ronan JJ, Harper CM, Beall MJ, Hanaway M, Fairhurst AM, Van der Ploeg LH, MacIntyre DE, Mellin TN 1998 Melano-cortin mediated inhibition of feeding behavior in rats. Neuropeptides 32:491-497
16. McMinn JE, Wilkinson CW, Havel PJ, Woods SC, Schwartz MW 2000 Effect of intracerebroventricular α-MSH on food intake, adiposity, c-Fos induction, and neuropeptide expression. Am J Physiol Regul Integr Comp Physiol 279:R695-R703
17. Pierroz DD, Ziotopoulou M, Ungsunan L, Moschos S, Flier JS, Mantzoros CS 2002 Effects of acute and chronic administration of the melanocortin agonist MTII in mice with diet-induced obesity. Diabetes 51:1337-1345
18. Krude H, Biebermann H, Luck W, Horn R, Brabant G, Gruters A 1998 Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet 19:155-157
19. Yaswen L, Diehl N, Brennan MB, Hochgeschwender U 1999 Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin. Nat Med 5:1066-1070
20. Farooqi IS, Yeo GS, Keogh JM, Aminian S, Jebb SA, Butler G, Cheetham T, O'Rahilly S 2000 Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency. J Clin Invest 106:271-279
21. Mergen M, Mergen H, Ozata M, Oner R, Oner C 2001 A novel melanocortin 4 receptor (MC4R) gene mutation associated with morbid obesity. J Clin Endocrinol Metab 86:3448
22. Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR, Gu W, Kesterson RA, Boston BA, Cone RD, Smith FJ, Campfield LA, Burn P, Lee F 1997 Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88:131-141
23. Vaisse C, Clement K, Guy-Grand B, Froguel P 1998 A frameshift mutation in human MC4R is associated with a dominant form of obesity. Nat Genet 20:113-114
24. Thornton JE, Cheung CC, Clifton DK, Steiner RA 1997 Regulation of hypothalamic proopiomelanocortin mRNA by leptin in ob/ob mice. Endocrinology 138:5063-5066
25. Satoh N, Ogawa Y, Katsuura G, Numata Y, Masuzakl H, Yoshimasa Y, Nakao K 1998 Satiety effect and sympathetic activation of leptin are mediated by hypothalamic melanocortin system. Neurosci Lett 249:107-110
26. Mizuno TM, Kleopoulos SP, Bergen HT, Roberts JL, Priest CA, Mobbs CV 1998 Hypothalamic pro-opiomelanocortin mRNA is reduced by fasting and [corrected] in ob/ob and db/db mice, but is stimulated by leptin. Diabetes 47:294-297
27. Schwartz MW, Seeley RJ, Woods SC, Weigle DS, Campfield LA, Burn P, Baskin DG 1997 Leptin increases hypothalamic pro-opiomelanocortin mRNA expression in the rostral arcuate nucleus. Diabetes 46:2119-2123
28. Bjorbaek C, Uotani S, da Silva B, Flier JS 1997 Divergent signaling capacities of the long and short isoforms of the leptin receptor. J Biol Chem 272:32686-32695
29. Tartaglia LA 1997 The leptin receptor. J Biol Chem 272:6093-6096
30. Baumann H, Morella KK, White DW, Dembski M, Bailon PS, Kim H, Lai CF, Tartaglia LA 1996 The full-length leptin receptor has signaling capabilities of interleukin 6-type cytokine receptors. Proc Natl Acad Sci USA93:8374-8378
31. Ghilardi N, Skoda RC 1997 The leptin receptor activates janus kinase 2 and signals for proliferation in a factor-dependent cell line. Mol Endocrinol 11:393-399
32. Banks AS, Davis SM, Bates SH, Myers Jr MG 2000 Activation of downstream signals by the long form of the leptin receptor. J Biol Chem 275:14563-14572
33. Stahl N, Farruggella TJ, Boulton TG, Zhong Z, Darnell Jr JE, Yancopoulos GD 1995 Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors. Science 267:1349-1353
34. Bjorbak C, Lavery HJ, Bates SH, Olson RK, Davis SM, Flier JS, Myers Jr MG 2000 SOCS3 mediates feedback inhibition of the leptin receptor via Tyr985. J Biol Chem 275:40649-40657
35. Ihle JN 1995 Cytokine receptor signalling. Nature 377:591-594
36. Li C, Friedman JM 1999 Leptin receptor activation of SH2 domain containing protein tyrosine phosphatase 2 modulates Ob receptor signal transduction. Proc Natl Acad Sci USA 96:9677-9682
37. White DW, Kuropatwinski KK, Devos R, Baumann H, Tartaglia LA 1997 Leptin receptor (OB-R) signaling. Cytoplasmic domain mutational analysis and evidence for receptor homo-oligomerization. J Biol Chem 272:4065-4071
38. Hubschle T, Thom E, Watson A, Roth J, Klaus S, Meyerhof W 2001 Leptin-induced nuclear translocation of STAT3 immunoreactivity in hypothalamic nuclei involved in body weight regulation. J Neurosci 21:2413-2424
39. Hosoi T, Kawagishi T, Okuma Y, Tanaka J, Nomura Y 2002 Brain stem is a direct target for leptin's action in the central nervous system. Endocrinology 143:3498-3504
40. Vaisse C, Halaas JL, Horvath CM, Darnell Jr JE, Stoffel M, Friedman JM 1996 Leptin activation of Stat3 in the hypothalamus of wild-type and ob/ob mice but not db/db mice. Nat Genet 14:95-97
41. El-Haschimi K, Pierroz DD, Hileman SM, Bjorbaek C, Flier JS 2000 Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity. J Clin Invest 105:1827-1832
42. Bousquet C, Zatelli MC, Melmed S 2000 Direct regulation of pituitary proopiomelanocortin by STAT3 provides a novel mechanism for immunoneuroendocrine interfacing. J Clin Invest 106:1417-1425
43. Shimon I, Yan X, Ray DW, Melmed S 1997 Cytokine-dependent gp130 receptor subunit regulates human fetal pituitary adrenocorticotropin hormone and growth hormone secretion. J Clin Invest 100:357-363
44. Bjorbaek C, Elmquist JK, Frantz JD, Shoelson SE, Flier JS 1998 Identification of SOCS-3 as a potential mediator of central leptin resistance. Mol Cell 1:619-625
45. Paxinos G, Watson C 1998 The rat brain in stereotaxic coordinates, 4th ed. San Diego: Academic Press
46. Cheung CC, Clifton DK, Steiner RA 1997 Proopiomelanocortin neurons are direct targets for leptin in the hypothalamus. Endocrinology 138:4489-4492
47. Harris M, Aschkenasi C, Elias CF, Chandrankunnel A, Nillni EA, Bjoorbaek C, Elmquist JK, Flier JS, Hollenberg AN 2001 Transcriptional regulation of the thyrotropin-releasing hormone gene by leptin and melanocortin signaling. J Clin Invest 107:111-120
48. Horvath CM, Wen Z, Darnell Jr JE 1995 A STAT protein domain that determines DNA sequence recognition suggests a novel DNA-binding domain. Genes Dev 9:984-994
49. Seidel HM, Milocco LH, Lamb P, Darnell Jr JE, Stein RB, Rosen J 1995 Spacing of palindromic half sites as a determinant of selective STAT (signal transducers and activators of transcription) DNA binding and transcriptional activity. Proc Natl Acad Sci USA 92:3041-3045
50. Wagner BJ, Hayes TE, Hoban CJ, Cochran BH 1990 The SIF binding element confers sis/PDGF inducibility onto the c-fos promoter. EMBO J 9:4477-4484
51. Bloch B, Bugnon C, Fellmann D, Lenys D, Gouget A 1979 Neurons of the rat hypothalamus reactive with antisera against endorphins, ACTH, MSH and β-LPH. Cell Tissue Res 204:1-15
52. Civelli O, Birnberg N, Herbert E 1982 Detection and quantitation of proopiomelanocortin mRNA in pituitary and brain tissues from different species. J Biol Chem 257:6783-6787
53. Mihaly E, Fekete C, Tatro JB, Liposits Z, Stopa EG, Lechan RM 2000 Hypophysiotropic thyrotropin-releasing hormone-synthesizing neurons in the human hypothalamus are innervated by neuropeptide Y, agouti-related protein, and α-melanocyte-stimulating hormone. J Clin Endocrinol Metab 85:2596-2603
54. Nilaver G, Zimmerman EA, Defendini R, Liotta AS, Krieger DT, Brownstein MJ 1979 Adrenocorticotropin and β-lipotropin in the hypothalamus. Localization in the same arcuate neurons by sequential immunocytochemical procedures. J Cell Biol 81:50-58
55. Bagnol D, Lu XY, Kaelin CB, Day HE, Ollmann M, Gantz I, Akil H, Barsh GS, Watson SJ 1999 Anatomy of an endogenous antagonist: relationship between Agouti-related protein and proopiomelanocortin in brain. J Neurosci 19(RC26):1-7
56. Marks DL, Butler AA, Cone RD 2002 Melanocortin pathway: animal models of obesity and disease. Ann Endocrinol (Paris) 63:121-124
57. Niswender KD, Morton GJ, Steams WH, Rhodes CJ, Myers Jr MG, Schwartz MW 2001 Intracellular signalling. Key enzyme in leptin-induced anorexia. Nature 413:794-795
58. Horsch D, Kahn CR 1999 Region-specific mRNA expression of phosphatidylinositol 3-kinase regulatory isoforms in the central nervous system of C57BL/6J mice. J Comp Neurol 415:105-120
59. Zhao AZ, Huan JN, Gupta S, Pal R, Sahu A 2002 A phosphatidylinositol 3-kinase phosphodiesterase 3B-cyclic AMP pathway in hypothalamic action of leptin on feeding. Nat Neurosci 5:727-728
60. Bjorbaek C, Buchholz RM, Davis SM, Bates SH, Pierroz DD, Gu H, Neel BG, Myers Jr MG, Flier JS 2001 Divergent roles of SHP-2 in ERK activation by leptin receptors. J Biol Chem 276:4747-4755
61. Schipper HM, Agarwal-Mawal A, Paudel HK 1999 The topography and subcellular distribution of mitogen-activated protein kinase kinase 1 (MEK1) in adult rat brain and differentiating PC12 cells. Neuroscience 93:585-595
62. Takeda T, Kurachi H, Yamamoto T, Nishio Y, Nakatsuji Y, Morishige K, Miyake A, Murata Y 1998 Crosstalk between the interleukin-6 (IL-6)-JAK-STAT and the glucocorticoid-nuclear receptor pathway: synergistic activation of IL-6 response element by IL-6 and glucocorticoid. J Endocrinol 159:323-330
63. Cantwell CA, Sterneck E, Johnson PF 1998 Interleukin-6-specific activation of the C/EBPδ gene in hepatocytes is mediated by Stat3 and Sp1. Mol Cell Biol 18:2108-2117
64. Too CK 1997 Induction of Sp1 activity by prolactin and interleukin-2 in Nb2 T- cells: differential association of Sp1-DNA complexes with Stats. Mol Cell Endocrinol 129:7-16
65. Coffer P, de Jonge M, Mettouchi A, Binetruy B, Ghysdael J, Kruijer W 1994 junB promoter regulation: Ras mediated transactivation by c-Ets-1 and c- Ets-2. Oncogene 9:911-921
66. Nillni EA, Vaslet C, Harris M, Hollenberg A, Bjorbak C, Flier JS 2000 Leptin regulates prothyrotropin-releasing hormone biosynthesis. Evidence for direct and indirect pathways. J Biol Chem 275:36124-36133
67. Broberger C, De Lecea L, Sutcliffe JG, Hokfelt T 1998 Hypocretin/orexin- and melanin-concentrating hormone-expressing cells form distinct populations in the rodent lateral hypothalamus: relationship to the neuropeptide Y and agouti gene-related protein systems. J Comp Neurol 402:460-474
68. Palkovits M, Mezey E, Eskay RL 1987 Pro-opiomelanocortin-derived peptides (ACTH/β-endorphin/α-MSH) in brainstem baroreceptor areas of the rat. Brain Res 436:323-338
69. Elias CF, Kelly JF, Lee CE, Ahima RS, Drucker DJ, Saper CB, Elmquist JK 2000 Chemical characterization of leptin-activated neurons in the rat brain. J Comp Neurol 423:261-281
70. Grill HJ, Schwartz MW, Kaplan JM, Foxhall JS, Breininger J, Baskin DG 2002 Evidence that the caudal brainstem is a target for the inhibitory effect of leptin on food intake. Endocrinology 143:239-246
71. Schwartz GJ, Moran TH 2002 Leptin and neuropeptide Y have opposing modulatory effects on nucleus of the solitary tract neurophysiological responses to gastric loads: implications for the control of food intake. Endocrinology 143:3779-3784
72. Yuan C-S, Attele AS, Dey L, Xie J-T 2000 Gastric effects of cholecystokinin and its interaction with leptin on brainstem neuronal activity in neonatal rats. J Pharmacol Exp Ther 295:177-182
73. Bates SH, Steams WH, Dundon TA, Schubert M, Tso AW, Wang Y, Banks AS, Lavery HJ, Haq AK, Maratos-Flier E, Neel BG, Schwartz MW, Myers Jr MG 2003 STAT3 signalling is required for leptin regulation of energy balance but not reproduction. Nature 421:856-859